FDA NDC Directory · JSON-LD · Markdown

OGIVRI

NDC 83257-003 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nametrastuzumab-dkst
Labeler / ManufacturerBiocon Biologics Inc.
Marketing categoryBiologic License Application · App BLA761074
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTRASTUZUMAB (420 mg/20mL)
Marketing started20231001
Package count0

External sources

Source: openFDA. Public-domain (CC0).